PHAT
Phathom Pharmaceuticals Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$10.37
+0.15 ▲ +1.47%
🌙 3월 13일 6:26 PM ET (한국 3/14 07:26)
$10.84
+0.47 ▲ +4.51%
| Index | RUT | P/E | - | EPS (ttm) | -3.05 | Insider Own | 39.34% | Shs Outstand | 0.07B | Perf Week | -2.81% |
| Market Cap | 0.82B | Forward P/E | 7.67 | EPS next Y | 4455.45% | Insider Trans | - | Shs Float | 0.05B | Perf Month | -15.21% |
| Enterprise Value | 1.28B | PEG | - | EPS next Q | -0.27 | Inst Own | 47.62% | Short Float | 23.37% | Perf Quarter | -28.73% |
| Income | -0.22B | P/S | 4.67 | EPS this Y | 98.98% | Inst Trans | -0.15% | Short Ratio | 9.82 | Perf Half Y | -14.01% |
| Sales | 0.18B | P/B | - | EPS next 5Y | - | ROA | -69.33% | Short Interest | 11.17M | Perf YTD | -37.49% |
| Book/sh | -6.14 | P/C | 6.29 | EPS past 3/5Y | 15.64% 4.82% | ROE | - | 52W High | -43.36% ($18.31) | Perf Year | 145.73% |
| Cash/sh | 1.65 | P/FCF | - | Sales past 3/5Y | - | ROIC | -179.72% | 52W Low | 369.23% ($2.21) | Perf 3Y | 45.03% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 43% | Gross Margin | 87.09% | Volatility(W/M) | 7.14% 7.38% | Perf 5Y | -77.05% |
| Dividend TTM | - | EV/Sales | 7.29 | Sales Y/Y TTM | 216.93% | Oper. Margin | -91.36% | ATR (14) | 0.87 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.69 | EPS Q/Q | 72.66% | Profit Margin | -126.35% | RSI (14) | 36.31 | Recom | 1.4 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.73 | Sales Q/Q | 94.12% | SMA20 | -9.99% ($11.52) | Beta | 0.62 | Target Price | $23.5 |
| Payout | - | Debt/Eq | - | Earnings | 2000000 | SMA50 | -21.24% ($13.17) | Rel Volume | 1.11 | Prev Close | $10.22 |
| Employees | 371 | LT Debt/Eq | - | EPS/Sales Surpr. | 29.61% 0.72% | SMA200 | -13.74% ($12.02) | Avg Volume(3M) | 1.14M | Price | $10.37 |
| IPO | 2019/10/25 | Option/Short | Yes/Yes | Trades | 9862 | Volume | 1,258,435 | Change | 1.47% |
뉴스 로딩 중...